Application of 3D bioprinting in the prevention and the therapy for human diseases
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Rapid development of vaccines and therapeutics is necessary to tackle the emergence of new pathogens and infectious diseases. To speed up the drug discovery process, the conventional development pipeline can be retooled by introducing advanced in vitro models as alternatives to conventional infectious disease models and by employing advanced technology for the production of medicine and cell/drug delivery systems. In this regard, layer-by-layer construction with a 3D bioprinting system or other technologies provides a beneficial method for developing highly biomimetic and reliable in vitro models for infectious disease research. In addition, the high flexibility and versatility of 3D bioprinting offer advantages in the effective production of vaccines, therapeutics, and relevant delivery systems. Herein, we discuss the potential of 3D bioprinting technologies for the control of infectious diseases. We also suggest that 3D bioprinting in infectious disease research and drug development could be a significant platform technology for the rapid and automated production of tissue/organ models and medicines in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“Therefore, soft lithography with PDMS has evolved to create an organ-on-a-chip with the precise control of fluids and localization of specific cells to the desired position.(41) In addition, 3D bioprinting with PDMS has been attempted to construct a transparent and stable chip device, while cells are bioprinted inside…”
MethodThe return of a forgotten polymer—Polycaprolactone in the 21st century
Woodruff, M. A., & Hutmacher, D. W. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.002 · Cited by 4,033 · cited 1×
“In particular, PCL, an FDA-approved biomaterial, has been widely used as a drug delivery carrier in sutures, and as scaffolds for tissue repair due to its long-term stability and slow biodegradability.(38) However, because PCL is hydrophobic, cells hardly attach to their surface.”
BackgroundHCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H., & Cho, D.-W. (2014) · Nature Communications · doi:10.1038/ncomms4935 · Cited by 1,904 · cited 1×
“The encapsulated live cells in pre-gel solutions have been utilized as bioinks to 3D print the desired tissue structures.(23) Therefore, 3D bioprinting has recently begun to be used for engineering advanced in vitro models as well.”
MethodSelf-citationFrom 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Hinton, T. J., Jallerat, Q., Palchesko, R. N., Park, J. H., Grodzicki, M. S., Shue, H.-J., Ramadan, M. H., Hudson, A. R., & Feinberg, A. W. (2015) · Science Advances · doi:10.1126/sciadv.1500758 · Cited by 1,805
Recent advances in 3D printing of biomaterials
Chia, H. N., & Wu, B. M. (2015) · Journal of Biological Engineering · doi:10.1186/s13036-015-0001-4 · Cited by 1,734
SARS-CoV-2 productively infects human gut enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · Science · doi:10.1126/science.abc1669 · Cited by 1,573 · cited 1×
“A human intestinal organoid exhibited significant production of infective SARS-CoV-2 particles, suggesting a fecaloral transmission route.(108)”
BackgroundThree-dimensional bioprinting of thick vascularized tissues
Kolesky, D. B., Homan, K. A., Skylar-Scott, M. A., & Lewis, J. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521342113 · Cited by 1,492 · cited 3×
“Kolesky et al.(42) constructed perfusable 3D vascularized tissues using a multi-material 3D bioprinting method.”
BackgroundPrintability and shape fidelity of bioinks in 3D bioprinting
Schwab, A., Levato, R., D’Este, M., Piluso, S., Eglin, D., & Malda, J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00084 · Cited by 1,359 · cited 1×
“In recent tissue engineering investigations, the materials used in 3D bioprinting of tissues, organs, and therapeutic products are categorized into (1) biomaterial inks and (2) bioinks, depending on whether cells are encapsulated.(33) In this section, we discuss biomaterial inks and hydrogels applicable to formulate b…”
BackgroundLong‐term expanding human airway organoids for disease modeling
Sachs, N., Papaspyropoulos, A., Zomer‐van Ommen, D. D., Heo, I., Böttinger, L., Klay, D., Weeber, F., Huelsz‐Prince, G., Iakobachvili, N., Amatngalim, G. D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100300 · Cited by 1,082 · cited 1×
“In addition, human infant lung organoids have been developed to simulate a respiratory virus infection that commonly occurs in infants and children.(103,104) In particular, human organoids have quickly been utilized to Application of 3D bioprinting in the prevention and the therapy for human.”
Method3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts
Noor, N., Shapira, A., Edri, R., Gal, I., Wertheim, L., & Dvir, T. (2019) · Advanced Science · doi:10.1002/advs.201900344 · Cited by 1,042 · cited 1×
“Recently, this technology has been applied to various fabrication applications, such as for muscles, the heart, and blood vessels.(63,82,83) However, as the FRESH technique primarily depends on the cross-linking mediated by the chemical reaction between the bioink and the bath material, the selection of materials is r…”
MethodMicrofluidic Bioprinting of Heterogeneous 3D Tissue Constructs Using Low‐Viscosity Bioink
Colosi, C., Shin, S. R., Manoharan, V., Massa, S., Costantini, M., Barbetta, A., Dokmeci, M. R., Dentini, M., & Khademhosseini, A. (2016) · Advanced Materials · doi:10.1002/adma.201503310 · Cited by 863
Rapid COVID-19 vaccine development
Graham, B. S. (2020) · Science · doi:10.1126/science.abb8923 · Cited by 771
Bioprinting of 3D convoluted renal proximal tubules on perfusable chips
Homan, K. A., Kolesky, D. B., Skylar-Scott, M. A., Herrmann, J., Obuobi, H., Moisan, A., & Lewis, J. A. (2016) · Scientific Reports · doi:10.1038/srep34845 · Cited by 699
Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development
Ronaldson-Bouchard, K., & Vunjak-Novakovic, G. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.011 · Cited by 657
Yi, H.-G., Jeong, Y. H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0363-x · Cited by 634
Self-citationNew Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
Selective laser sintering (SLS) 3D printing of medicines
Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.082 · Cited by 577 · cited 2×
“Fina et al.177 prepared a paracetamol tablet using SLS with Kollicoat® IR or Eudragit® L100–55, which aided the sintering process using a Candurin® gold sheen.”
MethodSARS‐CoV‐2 targets neurons of 3D human brain organoids
Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020106230 · Cited by 518
Kim, B. S., Das, S., Jang, J., & Cho, D.-W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00808 · Cited by 465 · cited 1×
“Hydrogels for bioink are required to (1) flow under modest pressures, (2) solidify quickly, and (3) sustain adequate integrity after building up.(50,51) In the sol–gel transition process, fibers in solutions can be physically or chemically cross-linked by external stimuli, such as temperature, light source, or ion con…”
BackgroundSelf-citationSun, W., Starly, B., Daly, A. C., Burdick, J. A., Groll, J., Skeldon, G., Shu, W., Sakai, Y., Shinohara, M., Nishikawa, M., et al. (2020) · Biofabrication · doi:10.1088/1758-5090/ab5158 · Cited by 426
Self-citationLee, H., & Cho, D.-W. (2016) · Lab on a Chip · doi:10.1039/c6lc00450d · Cited by 363 · cited 3×
“Lee et al.27 presented a one-step fabrication approach for constructing an organ-on-a-chip with 3D bioprinting technology.”
BackgroundInfluentialSelf-citation3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection
Ortega-Prieto, A. M., Skelton, J. K., Wai, S. N., Large, E., Lussignol, M., Vizcay-Barrena, G., Hughes, D., Fleck, R. A., Thursz, M., Catanese, M. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02969-8 · Cited by 236 · cited 1×
“Adapted from Ortega-Prieto et al.(113) b Gut-on-a-chip for the study of Coxsackie B1 Virus (CVB1) infection.”
MethodReverse engineering human pathophysiology with organs-on-chips
Ingber, D. E. (2016) · Cell · doi:10.1016/j.cell.2016.02.049 · Cited by 212
Bioprinting towards physiologically relevant tissue models for pharmaceutics
Peng, W., Unutmaz, D., & Ozbolat, I. T. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.05.013 · Cited by 196
Cited by
Scaffold degradation in bone tissue engineering: An overview
Tajvar, S., Hadjizadeh, A., & Samandari, S. S. (2023) · International Biodeterioration & Biodegradation · doi:10.1016/j.ibiod.2023.105599 · Cited by 291
Emerging Functional Porous Scaffolds for Liver Tissue Engineering
Wang, J., Huang, D., Chen, D., Ren, H., & Zhao, Y. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403741 · Cited by 15
Metadata
- Authors
- Yi, H.-G., Kim, H., Kwon, J., Choi, Y.-J., Jang, J., & Cho, D.-W.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-05-14
- Volume
- 6
- Issue
- 1
- Pages
- 177-177
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W3163372156
- Cited by
- 164
- References
- 29
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.